Calcium Glu/nacl 1gm/100ml Soln
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
In the event that you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
Lifestyle & Tips
- This medication is given in a hospital or clinic setting, so lifestyle modifications are not typically applicable during administration.
- Follow your doctor's instructions regarding diet and other medications once discharged.
Available Forms & Alternatives
Available Strengths:
- Calcium Carb 1250mg/5ml Susp
- Calcium Chloride 10% Inj, 10ml
- Calcium Oyster Shell 500mg Tablets
- Calcium 500mg Tablets
- Calcium Acetate 667mg Capsules
- Calcium 600+d (400u) Tablets
- Calcium 600mg Tablets
- Calcium 600mg + D Tablets
- Calcium 500 W/vit D3 Tablets
- Calcium Citrate 250mg Tablets
- Calcium Antacid 500mg Chw Tablets
- Calcium Carb 500mg Chewtablets
- Calcium Acetate 667mg Tablets
- Calcium Carb 648mg Tablets
- Calcium 500mg W/ Vit D Chw Tablets
- Calcium Citrate W/ Vit D Tablets
- Calcium/d3 600mg-200iu Tablets
- Calcium 500mg Chewable Tablets
- Calcium Gluconate 10% Inj, 50ml
- Calcium Antacid 750mg Chw Tablets
- Calcium Citrate 200mg Tablets
- Calcium Citrate+d3 Tablets
- Calcium Gluconate 10% Inj, 10ml
- Calcium Glu/nacl 1gm/100ml Soln
- Cal Glu/nacl 2000mg/100ml Inj 100ml
- Cal Glu/nacl 1gm/50ml Inj, 50ml
- Calcium Gluc 100mg/ml Inj, 50ml
- Calcium Gluconate 10% Inj, 100ml
- Calcium Gluc 100mg/ml Inj, 100ml
- Calcium Gluc 100mg/ml Inj, 10ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high calcium levels, including:
+ Weakness
+ Confusion
+ Feeling tired
+ Headache
+ Upset stomach and vomiting
+ Constipation
+ Bone pain
Symptoms that may occur if the medication is administered too quickly, such as:
+ Flushing
+ Slow or abnormal heartbeat
+ Signs of low blood pressure, including severe dizziness or fainting
Tissue damage at the injection site, characterized by:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid
If you experience any of these symptoms, notify your doctor or nurse immediately.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
* Constipation
This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- If you feel any pain, burning, or swelling at the injection site, tell your nurse immediately.
- Report any new or worsening symptoms such as nausea, vomiting, constipation, increased thirst or urination, muscle weakness, confusion, or irregular heartbeats, as these could be signs of too much calcium.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have elevated calcium levels in your blood.
If you are currently taking ceftriaxone or digoxin.
Please note that this is not an exhaustive list of all potential interactions with this medication. To ensure your safety, it is crucial to disclose all of your medications, including:
Prescription and over-the-counter (OTC) drugs
Natural products
Vitamins
Additionally, inform your doctor about any existing health problems. It is vital to verify that it is safe to take this medication in conjunction with your other medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Additionally, this medication may contain aluminum, which can increase the risk of aluminum toxicity with long-term use. This risk is particularly higher if you have kidney problems or if you are a premature infant. It is vital to discuss this potential risk with your doctor.
If you are pregnant, planning to become pregnant, or breastfeeding, you must consult your doctor to weigh the benefits and risks of this medication to both you and your baby. Your doctor will help you make an informed decision about using this medication during this time.
Overdose Information
Overdose Symptoms:
- Severe hypercalcemia (calcium levels too high)
- Nausea, vomiting, constipation
- Polyuria (frequent urination), polydipsia (excessive thirst)
- Muscle weakness, fatigue, lethargy
- Confusion, stupor, coma
- Shortened QT interval on ECG, bradycardia, arrhythmias, cardiac arrest
What to Do:
Immediately discontinue calcium gluconate. Administer IV fluids (0.9% NaCl) to promote renal calcium excretion. Loop diuretics (e.g., furosemide) may be used after adequate hydration. In severe cases, calcitonin, bisphosphonates, or hemodialysis may be necessary. Call 1-800-222-1222 (Poison Control) for further guidance.
Drug Interactions
Contraindicated Interactions
- Digoxin (concurrent IV administration in non-life-threatening hypocalcemia due to increased risk of arrhythmias)
- Ceftriaxone (in neonates, due to risk of precipitation in lungs and kidneys)
Major Interactions
- Digoxin (increased risk of cardiac arrhythmias, especially with rapid IV calcium or hypercalcemia)
- Thiazide diuretics (may increase serum calcium levels, leading to hypercalcemia)
- Phosphate-containing solutions (risk of calcium phosphate precipitation)
- Sodium polystyrene sulfonate (risk of intestinal necrosis with sorbitol-containing formulations)
Moderate Interactions
- Calcium channel blockers (calcium may antagonize the effects of CCBs)
- Tetracyclines (oral calcium can chelate and reduce absorption of oral tetracyclines; not relevant for IV calcium gluconate)
- Fluoride (may form insoluble calcium fluoride)
Monitoring
Baseline Monitoring
Rationale: To establish baseline and guide initial dosing for hypocalcemia; to assess calcium status in other indications.
Timing: Prior to administration
Rationale: To assess overall electrolyte balance, especially in hyperkalemia or magnesium toxicity; to identify potential for precipitation with phosphate.
Timing: Prior to administration
Rationale: To assess kidney's ability to excrete calcium and guide fluid management.
Timing: Prior to administration
Rationale: To assess cardiac rhythm and identify signs of hypocalcemia (prolonged QT) or hyperkalemia (peaked T waves, wide QRS).
Timing: Prior to administration, especially in cardiac-related indications
Routine Monitoring
Frequency: Every 4-6 hours initially, then daily or as clinically indicated during continuous infusion.
Target: Ionized: 1.12-1.32 mmol/L (4.5-5.3 mg/dL); Total: 8.5-10.5 mg/dL
Action Threshold: Ionized < 1.12 mmol/L (consider additional bolus/infusion increase); Ionized > 1.32 mmol/L (consider infusion decrease/discontinuation).
Frequency: Daily or as clinically indicated.
Target: Normal physiological ranges
Action Threshold: Significant deviations from normal (e.g., hyperphosphatemia, hypomagnesemia) may require intervention.
Frequency: Continuous monitoring during rapid IV infusion; periodically during continuous infusion.
Target: Normal sinus rhythm, absence of arrhythmias
Action Threshold: Development of bradycardia, arrhythmias, or signs of hypercalcemia (shortened QT interval).
Frequency: Every 15-30 minutes during rapid infusion, then every 1-4 hours.
Target: Within patient's normal range
Action Threshold: Significant bradycardia, hypotension, or hypertension.
Frequency: Regularly (e.g., every 1-2 hours) during infusion.
Target: No signs of redness, swelling, pain, or extravasation.
Action Threshold: Any signs of extravasation (stop infusion immediately).
Symptom Monitoring
- Signs of hypercalcemia (nausea, vomiting, constipation, polyuria, polydipsia, muscle weakness, confusion, lethargy, cardiac arrhythmias)
- Signs of hypocalcemia (paresthesias, muscle cramps, tetany, Chvostek's sign, Trousseau's sign, seizures, cardiac arrhythmias)
- Symptoms of extravasation (pain, swelling, redness at injection site)
Special Patient Groups
Pregnancy
Category C. Calcium is essential for fetal development. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Close monitoring of maternal calcium levels is recommended.
Trimester-Specific Risks:
Lactation
Calcium is a natural component of breast milk. While IV administration can transiently increase maternal serum calcium, significant adverse effects on the infant are not expected with therapeutic doses. Monitor infant for signs of hypercalcemia if concerns arise.
Pediatric Use
Dosing is weight-based and varies by indication. Careful calculation and slow administration are crucial to avoid hypercalcemia and cardiac effects. Neonates are particularly sensitive to rapid calcium infusions and precipitation with ceftriaxone.
Geriatric Use
Use with caution in elderly patients, who may have age-related decreases in renal function. Monitor serum calcium and renal function closely. Start at the lower end of the dosing range and titrate based on response and tolerability.
Clinical Information
Clinical Pearls
- Administer IV calcium gluconate slowly (typically over 5-10 minutes for bolus doses) to minimize the risk of hypotension, bradycardia, and cardiac arrhythmias.
- Calcium gluconate is less irritating to veins than calcium chloride and is preferred for peripheral IV administration, though central line is preferred for continuous infusions or high doses.
- Avoid extravasation, as it can cause severe tissue necrosis and calcification. If extravasation occurs, stop infusion immediately, aspirate residual drug, and consider hyaluronidase injection.
- Do NOT administer calcium gluconate concurrently with ceftriaxone in neonates due to the risk of fatal calcium-ceftriaxone precipitation in the lungs and kidneys.
- Monitor ECG continuously during rapid IV administration, especially in patients on digoxin, due to the risk of potentiating digoxin toxicity.
- Calcium gluconate provides 90 mg (4.5 mEq) of elemental calcium per 1 gram (10 mL of 10% solution), whereas calcium chloride provides 270 mg (13.6 mEq) of elemental calcium per 1 gram (10 mL of 10% solution). Dosing must be adjusted accordingly if switching between formulations.
Alternative Therapies
- Calcium Chloride (provides more elemental calcium per gram, but is more irritating to veins and typically reserved for central line administration or cardiac arrest)
- Oral Calcium Supplements (for chronic hypocalcemia or prevention)
- Magnesium Sulfate (for hypomagnesemia)
- Sodium Bicarbonate (for hyperkalemia, but mechanism differs)
Cost & Coverage
General Drug Facts
All medications should be stored in a secure location, out of the reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless specifically instructed to do so by a healthcare professional or pharmacist, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the proper disposal method, consult with your pharmacist, who can provide guidance on safe disposal practices or inform you about potential drug take-back programs in your area.
Some medications may come with an additional patient information leaflet, so it is a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider.
In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide critical information, including the name of the medication taken, the amount, and the time it was taken, to ensure prompt and effective treatment.